Reaction
Coma Hepatic reporting signals
As of the last recalculation, Coma Hepatic appears in 740 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is SORAFENIB (PRR 52.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Sorafenib | 37 | 52.7 | 52.8 |
| Rifampicin | 14 | 39.7 | 39.7 |
| Regorafenib | 13 | 32.0 | 32.1 |
| Isoniazid | 16 | 28.4 | 28.4 |
| Pyrazinamide | 9 | 27.3 | 27.3 |
| Entecavir | 9 | 21.9 | 22.0 |
| Sofosbuvir | 11 | 15.9 | 15.9 |
| Fosaprepitant Dimeglumine | 7 | 14.4 | 14.5 |
| Bleomycin Sulfate | 5 | 13.7 | 13.7 |
| Alpelisib | 4 | 13.0 | 13.0 |
| Rifaximin | 9 | 12.2 | 12.2 |
| Methadone Hydrochloride | 4 | 10.4 | 10.5 |
| Abiraterone | 5 | 10.4 | 10.4 |
| Abemaciclib | 7 | 9.9 | 9.9 |
| Crizotinib | 3 | 6.7 | 6.7 |